Holobionts: emerging strategy for interventions against infectious diseases, metabolic disorders & cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4181143)

Published in Indian J Med Res on July 01, 2014

Authors

Yadvir Singh, Seyed E Hasnain1

Author Affiliations

1: Kusuma School of Biological Sciences Indian Institute of Technology, Hauz Khas New Delhi 110 067; Dr Reddy's Institute of Life Sciences University of Hyderabad Campus, Gachibowli Professor C.R. Rao Road Hyderabad 500 046, India.

Articles cited by this

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11

Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07

Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife (2013) 5.49

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (2013) 5.09

The role of microorganisms in coral health, disease and evolution. Nat Rev Microbiol (2007) 4.95

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature (2013) 3.03

Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76

Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention. Nat Rev Microbiol (2008) 1.96

PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell (2014) 1.51

Retracted Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes (2014) 1.07

Virulence or niche factors: what's in a name? J Bacteriol (2012) 1.05

Evolving insights: symbiosis islands and horizontal gene transfer. J Bacteriol (2002) 1.02

Typhoid Mary. Lancet (1999) 0.92

Emerging importance of holobionts in evolution and in probiotics. Gut Pathog (2013) 0.84